Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Viracta Therapeutics Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-11-25
Sale
2022-11-29
5:33 pm
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
3,532 $2.7196 $9,606 154,621
(Direct)
View
2022-11-25
Sale
2022-11-29
5:25 pm
Viracta Therapeutics Inc. VIRX Rojkjaer Lisa
Chief Medical Officer
2,116 $2.7193 $5,754 87,389
(Direct)
View
2022-08-25
Sale
2022-08-29
9:18 pm
Viracta Therapeutics Inc. VIRX Rojkjaer Lisa
Chief Medical Officer
2,190 $4.0118 $8,786 89,505
(Direct)
View
2022-08-25
Sale
2022-08-29
9:14 pm
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
3,655 $4.0162 $14,679 158,153
(Direct)
View
2022-08-25
Sale
2022-08-29
9:11 pm
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
13,379 $4.0105 $53,656 908,778
(Indirect
Direct)
View
2022-05-25
Sale
2022-05-27
5:34 pm
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
13,162 $1.9011 $25,022 922,157
(Indirect
Direct)
View
2022-05-25
Sale
2022-05-27
5:32 pm
Viracta Therapeutics Inc. VIRX Rojkjaer Lisa
Chief Medical Officer
2,154 $1.9011 $4,095 91,695
(Direct)
View
2022-05-25
Sale
2022-05-27
5:27 pm
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
3,596 $1.9011 $6,836 161,808
(Direct)
View
2022-02-25
Sale
2022-03-01
9:13 pm
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
14,635 $2.7795 $40,678 935,319
(Indirect
Direct)
View
2022-02-25
Sale
2022-03-01
9:12 pm
Viracta Therapeutics Inc. VIRX Rojkjaer Lisa
Chief Medical Officer
2,395 $2.7795 $6,657 93,849
(Direct)
View
2022-02-25
Sale
2022-03-01
9:10 pm
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
3,998 $2.7795 $11,112 165,404
(Direct)
View
2021-11-25
Sale
2021-11-29
7:50 pm
Viracta Therapeutics Inc. VIRX Rojkjaer Lisa
Chief Medical Officer
4,541 $4.8112 $21,847 96,244
(Direct)
View
2021-11-25
Sale
2021-11-29
7:48 pm
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
7,579 $4.8112 $36,464 169,402
(Direct)
View
2021-11-25
Sale
2021-11-29
7:46 pm
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
27,747 $4.8112 $133,495 942,954
(Indirect
Direct)
View
2021-11-15
Purchase
2021-11-15
5:59 pm
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
8,000 $5.56 $44,480 567,198
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-11-25
Exercise
2022-11-29
5:33 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
6,889 $0 154,621
(Direct)
View
2022-11-25
Exercise
2022-11-29
5:25 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Rojkjaer Lisa
Chief Medical Officer
4,127 $0 87,389
(Direct)
View
2022-11-25
Exercise
2022-11-29
5:21 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Pomerantz Roger
Director
9,034 $0 144,547
(Direct)
View
2022-11-25
Exercise
2022-11-29
5:18 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
Director
25,219 $0 908,778
(Direct)
View
2022-09-19
Option Award
2022-09-19
7:04 pm
N/A
2032-09-19
Viracta Therapeutics Inc. VIRX Rothera Mark
CEO
1,375,000 $0 1,375,000
(Direct)
View
2022-08-25
Exercise
2022-08-29
9:18 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Rojkjaer Lisa
Chief Medical Officer
4,127 $0 89,505
(Direct)
View
2022-08-25
Exercise
2022-08-29
9:16 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Pomerantz Roger
Director
9,034 $0 144,547
(Direct)
View
2022-08-25
Exercise
2022-08-29
9:14 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
6,889 $0 158,153
(Direct)
View
2022-08-25
Exercise
2022-08-29
9:11 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
25,219 $0 908,778
(Direct)
View
2022-08-10
Option Award
2022-08-11
7:01 pm
N/A
2032-08-10
Viracta Therapeutics Inc. VIRX Pomerantz Roger
Director
30,282 $0 30,282
(Direct)
View
2022-08-10
Option Award
2022-08-11
6:58 pm
N/A
2032-08-10
Viracta Therapeutics Inc. VIRX Chung Jane
Director
80,000 $0 80,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
5:16 pm
N/A
2032-06-09
Viracta Therapeutics Inc. VIRX Simon Barry J.
Director
40,000 $0 40,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
5:13 pm
N/A
2032-06-09
Viracta Therapeutics Inc. VIRX Rubino Stephen
Director
40,000 $0 40,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
5:10 pm
N/A
2032-06-09
Viracta Therapeutics Inc. VIRX Pomerantz Roger
Director
40,000 $0 40,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
5:07 pm
N/A
2032-06-09
Viracta Therapeutics Inc. VIRX ONETTO NICOLE
Director
40,000 $0 40,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
5:04 pm
N/A
2032-06-09
Viracta Therapeutics Inc. VIRX Murphy Samuel Lafayette
Director
40,000 $0 40,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:59 pm
N/A
2032-06-09
Viracta Therapeutics Inc. VIRX Huang Michael
Director
40,000 $0 40,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:56 pm
N/A
2032-06-09
Viracta Therapeutics Inc. VIRX DARCY THOMAS E
Director
40,000 $0 40,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:54 pm
N/A
2032-06-09
Viracta Therapeutics Inc. VIRX Borellini Flavia
Director
40,000 $0 40,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:51 pm
N/A
2032-06-09
Viracta Therapeutics Inc. VIRX Barlow Jane F
Director
40,000 $0 40,000
(Direct)
View
2022-05-25
Exercise
2022-05-27
5:34 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
25,219 $0 922,157
(Direct)
View
2022-05-25
Exercise
2022-05-27
5:32 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Rojkjaer Lisa
Chief Medical Officer
4,127 $0 91,695
(Direct)
View
2022-05-25
Exercise
2022-05-27
5:30 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Pomerantz Roger
Director
9,034 $0 144,547
(Direct)
View
2022-05-25
Exercise
2022-05-27
5:27 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
6,889 $0 161,808
(Direct)
View
2022-03-17
Option Award
2022-03-18
5:35 pm
N/A
2032-03-17
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
195,000 $0 195,000
(Direct)
View
2022-03-17
Option Award
2022-03-18
5:34 pm
N/A
2032-03-17
Viracta Therapeutics Inc. VIRX Rojkjaer Lisa
Chief Medical Officer
150,000 $0 150,000
(Direct)
View
2022-03-17
Option Award
2022-03-18
5:32 pm
N/A
2032-03-17
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
412,500 $0 412,500
(Direct)
View
2022-02-25
Exercise
2022-03-01
9:13 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
25,219 $0 935,319
(Direct)
View
2022-02-25
Exercise
2022-03-01
9:12 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Rojkjaer Lisa
Chief Medical Officer
4,127 $0 93,849
(Direct)
View
2022-02-25
Exercise
2022-03-01
9:11 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Pomerantz Roger
Director
9,034 $0 144,547
(Direct)
View
2022-02-25
Exercise
2022-03-01
9:10 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
6,889 $0 165,404
(Direct)
View
2021-12-29
Exercise
2021-12-30
6:47 pm
N/A
2029-02-13
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
7,000 $0 657,688
(Direct)
View
2021-12-29
Exercise
2021-12-30
6:47 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
7,000 $0.9 657,688
(Direct)
View
2021-11-25
Exercise
2021-11-29
7:51 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Pomerantz Roger
Director
18,068 $0 144,547
(Direct)
View
2021-11-25
Exercise
2021-11-29
7:50 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Rojkjaer Lisa
Chief Medical Officer
8,254 $0 96,244
(Direct)
View
2021-11-25
Exercise
2021-11-29
7:48 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
13,777 $0 169,402
(Direct)
View
2021-11-25
Exercise
2021-11-29
7:46 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX ROYSTON IVOR
CEO
50,437 $0 942,954
(Direct)
View
2021-09-28
Exercise
2021-09-29
6:04 pm
N/A
2029-07-30
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
10,000 $0 155,577
(Direct)
View
2021-09-28
Exercise
2021-09-29
6:04 pm
N/A
N/A
Viracta Therapeutics Inc. VIRX Chevallard Daniel R.
CFO
COO
10,000 $0.9 155,577
(Direct)
View
Goto 0, 1, 2, Next